Pediatric sedation
Conditions
Interventions
Test group:Subsequently, the child is administered 0.5 mg/kg of midazolam orally. After a waiting period of 5 minutes, a modified sequential method is employed to administer 1 mg/kg of esketamine intr
Sponsors
Sanya Women And Children's Hospital
Eligibility
Sex/Gender
All
Age
0.5 Years to 6 Years
Inclusion criteria
Inclusion criteria: Age from 6 months to 6 years old; ASA grade I-II; no mental disorders; no congenital systemic diseases; normal liver and kidney function
Exclusion criteria
Exclusion criteria: Children who are allergic to the medications used in this study;Children with severe liver and kidney dysfunction, children with infectious disease, children with asthma, and children with mental disorders Children who were using or had recently used (< 24 h) a sedative.) The child's guardian was consulted and informed consent was signed for the conduct of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sedative effect;Whether the sedation was successful or not; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pulse oxygen saturation;blood pressure;heart rate;Respiratory rate;The number of adverse events that occurred; Aldrete score; | — |
Countries
China
Contacts
Public ContactYujuan Tao
Sanya Women And Children's Hospital
Outcome results
None listed